A new AI-enhanced ECG model, AIRE, accurately predicts mortality and heart disease risk, providing clinicians with actionable ...

Patients with PM had the highest prevalence of ASCVD (30.4%), followed by those with DM (24.3%) and DPM (14.8%), while individuals with JDM showed a prevalence below 1%. Patients with PM had a higher ...

Background: Current atherosclerotic cardiovascular disease (ASCVD) risk assessment tools like the Pooled Cohort Equations (PCEs) and PREVENT™ scores offer long-term predictions but may not effectively ...

Comcast is boasting about what it’s calling its “biggest week in internet history,” which it pegs on Call of Duty: Black Ops 6 downloads and Thursday Night Football streams. The company says ...

“Our results may inform clinical risk stratification along with monitoring and management to help to protect kidney function in people with ASCVD,” Dr Tuttle’s team concluded in their poste ...

AI Death Predictor: Researchers have developed the AI-ECG Risk Estimator (AIRE), an AI mortality calculator that predicts health risks and lifespan based on ECG data. Set for trials in the UK next ...

An AI-enabled death calculator, developed by researchers, can predict future health risks and potential death using electrocardiograms or ECG. Listen to Story An AI-ECG Risk Estimator is a tool that ...

The doctor recommends a risk assessment tool called the Tyrer-Cuzick Risk Assessment Calculator, which we’re linking to here. Though it’s not a diagnostic tool, it only takes minutes and will ...

Opens in a new tab or window No evidence-based guidelines for reducing the risk of atherosclerotic cardiovascular disease (ASCVD) following chronic obstructive pulmonary disease (COPD ...

Recently, a new personalized risk estimator was developed that more accurately predicts metastasis and prostate cancer–specific death than National Comprehensive Cancer Network (NCCN) risk groups. 6 ...

This underscores the need for individuals with hypothyroidism to be proactive regarding ASCVD risk factors. A balanced Th1/Th2 and Th17/Treg ratio may offer a novel strategy in preventing CAD and ...

Participants included 7,731 PWH aged 40 to 75 years with a low-to-moderate risk for ASCVD, without DM at study entry, who were randomly assigned to pitavastatin 4 mg daily or placebo in a 1:1 ratio.